Observation of hepatotoxicity during long-term gefitinib administration in patients with non-small-cell lung cancer

To observe drug-induced hepatotoxicity by long-term gefitinib administration in the treatment of non-small-cell lung cancer. The data of 101 patients with locally advanced or metastatic non-small-cell lung cancer, for which gefitinib had been used orally for 3 months or longer, were retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jingjing, Wu, Yanlin, Dong, Mei, He, Xiaohui, Wang, Ziping, Li, Junling, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736296/
https://www.ncbi.nlm.nih.gov/pubmed/26633888
http://dx.doi.org/10.1097/CAD.0000000000000323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736296/
https://www.ncbi.nlm.nih.gov/pubmed/26633888
http://dx.doi.org/10.1097/CAD.0000000000000323

Ejemplares similares